You searched for "ERS"

718 results found

Soluvos Medical brings laryngology products to their customers!

Soluvos Medical is still hoping that 2021 will bring social life, travels and meetings back to normal and that they can finally meet readers again at one of the yet-to-be-scheduled meetings later in the year.

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....

In conversation with Professor Eugene Myers: My life in ENT

In a series of interviews, former Chairman of the Editorial Board for ENT & audiology news, Professor Patrick J Bradley, speaks with eminent otolaryngologists who have retired (or are about to retire) from practice. Our first is with Professor Gene...

Young ESPO – looking back and looking ahead

In 2018, after the virtual ESPO Marseille meeting, a new committee of ESPO Juniors was established. Last year, the name was changed to Young ESPO.

ENT in this issue...IFOS Vancouver

The COVID-19 pandemic has caused us great concern for the health and safety of our patients, communities and colleagues around the world. Although we continue to plan for IFOS 2021 in Vancouver, Canada, at this time, we must plan for...

Coros: can a smart helmet make listening to audio content safer for cyclists?

The popularity of mobile phones has made listening to content while on the go – whether it be music, audiobooks, podcasts, or voice calls – a seemingly universal practice. Earbuds and other headphone styles adorn the ears of nearly every...

IFOS Dubai 2023

Hussain Abdul Rahman Al Rand, Msc (Cairo), German Board (Facharzt), FRCS (Edin), President, IFOS World Congress Dubai, 2023; Assistant Under Secretary Public Health, Ministry of Health and Prevention, UAE; Vice President, IFOS; President, ARABFOS, GCC ORL Head and Neck Society,...

Omalizumab for CRSwNP: a monoclonal antibody

A prospective study from London, evaluating the response of chronic rhinosinusitis patients with nasal polyposis who were being treated with monoclonal antibody against IgE for severe allergic asthma. Thirteen patients were treated with Omalizumab, according to UK guidelines for their...

Time to endoscopic sinus surgery and outcomes

A well written prospective study, which demonstrates that patients who require endoscopic sinus surgery, should be operated on without long delay since this achieves better and more sustained outcomes. There were 1493 patients undergoing primary nasal surgery who had completed...

Updates on current evidence for biologics in chronic rhinosinusitis

For a comparatively short piece, this article manages to pack in a lot of important information about a complex emerging area of rhinology – immunologically targeted therapy (biologics). Immunologically targeted therapy is a rapidly progressing and expanding domain which is...

Chronic rhinosinusitis – a pre-malignant condition?

Nasopharyngeal carcinoma (NPC) is a relatively uncommon diagnosis in the West but is prevalent in Southeast Asia. Several factors have been established to be associated with a higher risk of developing NPC, including salted fish consumption, smoking, alcohol, and Epstein...

The future of rhinology: What will come first, a radical change in rhinological management or the decimation of the world?

In this article, Simon Gane looks forward to what the future holds, on the presumption he survives. Setting aside the questions of the UK even existing, the NHS still working, or the fact we’ll be commuting to our jobs in...